Analysis of epitope structure of PSP94 (prostate secretory protein of 94 amino acids): (I) Immuno-dominant and immuno-recessive area

Journal of Cellular Biochemistry

Volumn 65, Issue 2, 1997, Pages 172-185

  Xuan, Jim W ^a,c   Wu, Dongmei ^a   Guo, Yuzhen ^b   Garde, Seema ^b   Baijal Gupta, Madhulika ^b   Chin, Joseph L ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Procyon Biopharma Inc   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

competitive ELISA; ELISA; epitope structure; immuno recessive; immuno dominant; peptide mapping; recombinant GST PSP N terminal and C terminal peptides; recombinant GST PSP94

Indexed keywords

EPITOPE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN; SECRETORY PROTEIN; SYNTHETIC PEPTIDE;

AMINO TERMINAL SEQUENCE; ANTIGENICITY; ARTICLE; BINDING COMPETITION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN ANALYSIS;

ORYCTOLAGUS CUNICULUS;

EID: 0030907964     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(199705)65:2<172::AID-JCB4>3.0.CO;2-R     Document Type: Article

References (51)

1. Abrahamsson P-A, Lilja H, Falkmer S, Wadstrom LB (1988): Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Prostate 12:39-46.
2. Akiyama K, Yoshioka Y, Schmid K, Offner GD, Troxler RF, Tsunda R, Hara M (1985): The amino acid sequence of human β-microseminoprotein. Biochem Biophys Res Commun 829:288-294.
3. Arbatti NJ, Seidah NG, Rochemont J, Escher E, Sheth AR, Chretien M (1985): β-Inhibin contains the active core of human seminal plasma β-inhibin: Synthesis and bioactivity. FEBS Lett 181:57-63.
4. Baijal-Gupta M, Fraser M, Clarke J, Xuan JW, Finkelman MA (1996): A new scalable purification procedure tor prostatic secretory protein (PSP94) from human, seminal plasma. Protein Expression and Purification. 8:483-488.
5. Bautista DS, Xuan JW, Hota C, Chambers AF Harris JF (1994): Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin. J Biol Chem 269:23280-23285.
6. Brar A, Mbikay M, Sirois F, Fournier S, Seidah NG, Chretien M (1988): Localization of the human prostatic secretory protein PSP94 and its mRNA in the epithelial cells of the prostate. J Androl 9:253-260.
7. Carter D, Resnick MI (1982): High resolution analysis of human prostatic fluid by two-dimensional electrophoresis. Prostate 3:27-33.
8. Doctor VM, Sheth AR, Simha MM, Arbatti NJ, Aaveri JP, Sheth NA (1986): Studies on immunocytochemical localization of inhibin-like material in human prostate tissue: Comparison of its distribution in normal, benign and malignant prostates. Br J Cancer 53:547-554.
9. Dube JY, Frenette G, Paquin R, Chapdelaine P, Tremblay J, Tremblay RR, Lazure C, Seidah N, Chretien M (1987a): Isolation from human seminal plasma of an abundant 16-kDa protein originating from the prostate, its identification with a 94-residue peptide originally described as β-inhibin. J Androl 8:182-189.
10. Dube JY, Pelletier G, Gagnon P, Tremblay RR (1987b): Immunohistochemical localization of a prostatic secretory protein of 94 amino acids in normal prostatic tissue in primary prostatic tumours and in their metastasis. J Urol 138:883-887.
11. Garde SV, Sheth AR, Porter AT, Pienta KJ (1993): Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and vivo. Prostate 22:225-233.
12. Garde SV, Sheth AR, Shah MG, Kulkarni SA (1991): Prostate-an extrapituitary source of follicle-stimulating hormone (FSH): Occurrence, localization, and de novo biosynthesis and its hormonal modulation in primates and rodents. Prostate 18:271-287.
13. Garde SV, Sheth AR, Porter AT, Pienta KJ (1993): A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines. Cancer Lett 70:159-166.
14. Gordon WL, Liu WK, Akiyama K, Tsuda R, Hara M, Schmid K, Ward D (1987): Beta-microseminoprotein (β-MbP) is not an inhibin. Biol Reprod 36:829-835.
15. Green CB, Liu WY, Kwok SCM (1990): Cloning and nucleotide sequence analysis of the human β-microseminoprotein gene. Biochem Biophys Res Commun 167:1184-1190.
16. Hara M, Kimura H (1989): Two prostate-specific antigens, γ-seminoprotein and β-microseminoprotein. J Lab Clin Med 113:541-548.
17. Huang C, Liang HM, Brassil D, Schellhammer PF, Rozzel M, Newhall K, Beckett ML, Wright Jr GL (1992): Two-site monoclonal antibody-based immunoradiometric assay for measuring prostate secretory protein in serum. Clin Chem 38:817-823.
18. Huang C, Brassil D, Rozzel M, Schellhammer PF, Wright Jr GL (1993): Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma. Prostate 23:201-212.
19. Johansson J, Sheth A, Cederlund E, Jornvall H (1984): Analysis of an inhibin preparation reveals apparent identity between a peptide with inhibin-like activity and a sperm-coating antigen. FEBS Lett 176:21-26.
20. Kharbanda K, Duraiswami S (1990): Further studies on the synthesis and secretion of inhibin-like material by rat ventral prostate explants in vitro. Prostate 16:163-172.
21. Kohan S, Froysa B, Cederlund E, Fairwell T, Lerner R, Johansson J, Khan S, Ritzen M, Jornvall H, Cekan S, Diczfalusy E (1986): Peptides of postulated inhibin activity. Lack of in vitro inhibin activity of a 94-residue peptide isolated from human seminal plasma, and of a synthetic replicate of its C-terminal 28-residue segment. FEBS Lett 199:242-248.
22. Liang ZG, Kamada M, Koide SS (1991): Structural identity of immunoglobulin binding factor and prostatic secretory protein of human seminal plasma. Biochem Biophys Res Communm 180:356-359.
23. Liang ZG, Kamada M, Mitsudo SM, Koide SS (1992): Immunoglobulin binding factor of seminal plasma: a secretory product of human prostate. Arch Androl 28:159-164.
24. Linard CG, Mbikay M, Benjannet S, Lazure C, Seidah NG, Chretien M (1988): Correct processing and secretion of a human prostatic secretory protein (PSP94) in Escherichia coli. Gene 73:479-487.
25. Liu YA, Bradner RC, Vessella RL (1993): Decreased expression of prostatic secretory protein PSP94 in prostate cancer. Cancer Lett 74:91-99.
26. Lokeshwar BL, Hurkadli KS, Sheth AR, Block NL (1993): Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor. Cancer Res 53:4855-4859.
27. Maeda N, Kamada M, Daitoh T, Aono T, Futaki S, Liang ZG, Koide SS (1993): Immunoglobulin binding factor in human seminal plasma: Immunological function. Arch Androl 31:31-36.
28. Mahale SD, Sheth AR, Iyer KSN (1993): Studies on the carboxyl terminal peptides of human plasma inhibin (HSPI): chemical synthesis and in vivo biological activity of the disulfide loop peptide 67-94 of HSPI. Int J Peptide Res 42:132-137.
29. Mbikay M, Nolet S, Fournier S, Benjannet S, Chapdelaine P, Paradis G, Dube JY, Tremblay R, Lazure C, Seidah NS, Chretien M (1987): Molecular cloning and sequence of the cDNA for a 94-amino-acid seminal plasma protein secreted by the human prostate. DNA 6:23-29.
30. Mundel SD, Shedth NA (1993): Suppression of DNA synthesis and induction of apoptosis in rat prostate by human seminal plasma inhibin (HSPI). Cell Biol Int 17:587-594.
31. Nolet S, Mbikay M, Chretien M (1991a): Prostatic secretory protein PSP94: Gene organization and promoter sequence in Rhesus monkey and human. Biochim Biophys Acta 1089:247-249.
32. Nolet S, St-louis D, Mbikay M, Chretien M (1991b): Rapid evolution of prostatic protein PSP94 suggested by sequence divergence between Rhesus monkey and human cDNA. Genomics 9:775-777.
33. Ochiai Y, Inazawa J, Ueyama H, Ohkubo I (1995): Human gene for beta-microseminoprotein: Its promoter structure and chromosomal localization. J Biochem 117:346-352.
34. Sambrook J, Fritsch EF, Maniatis T (1989): "Molecular Cloning: A Laboratory Manual." Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
35. Seidah NG, Arbatti NJ, Rochemont J, Sheth AR, Chretien M (1984): Complete amino acid sequence of human seminal plasma β-inhibin. FEBS Lett 175:349-355.
36. Sheth AR, Teni TR, Sheth NA (1988): Human prostatic inhibin. In Imura HE (ed): "Progress in Endocrinology." New York: Elsevier Science Publishers B.V.
37. Teni TR, Bandivdekar AH, Sheth AR, Sheth NA (1989): Prostatic inhibin-like peptide quantified in urine of prostatic cancer patients by enzyme-linked immunosorbent assay. Clin Chem 35:1376-1379.
38. Tremblay J, Frenette G, Tremblay RR, Dupont A, Thabet M, Dube JY (1987): Excretion of three major prostatic secretory proteins in the urine of normal men and patients with benign prostatic hypotrophy or prostate cancer. Prostate 10:235-243.
39. Ulvsback M, Lindstrom C, Weiber H, Abrahamsson PA, Lilja H, Lundwall A (1989): Molecular cloning of a small prostate protein, known as β-microsemenoprotein, PSP94 or β-inhibin, and demonstration of transcripts in non-genital tissues. Biochem Biophys Res Commun 164:1310-1315.
40. Ulvsback M, Spurr NK, Lundwall A (1991): Assignment of the human gene for β-microseminoprotein (MSMB) to chromosome 10 and demonstration of related genes in other vertebrates. Genomics 11:920-924.
41. Vanage GR, Garde SV, Sheth AR, Gopalkrishnan K (1992): Passive immunization against prostatic 'inhibin' peptide as a male contraceptive. Int J Androl 15:114-126.
42. Vaze AY, Thakur AN, Sheth AR (1979): Development of a radio immunoassay for human seminal plasma inhibin. J Reprod Fert suppl. 26:135-146.
43. von der Kammer H, Krauhs E, Aumuller G, Scheit KH (1990): Characterization of a monoclonal antibody specific for prostatic secretory protein of 94 amino acids (PSP94) and development of a two-site binding enzyme immunoassay for PSP94. Clin Chim Acta 187:207-220.
44. Wright Jr. GL, Huang CL, Lipford G, Beckett ML, Liang HM, Haley C, Newhall K, Morningstar M (1990): Generation and characterization of monoclonal antibodies to prostate secretory protein. Int J Cancer 46:39-49.
45. Xuan JW, Hota C, Chambers AF (1994a): Recombinant GST-human osteopontin fusion protein is functional in RGD-dependent cell adhesion. J Cell Biochem 54:247-255.
46. Xuan JW, Kowalski J, Chambers AF, Denhardt DT (1994b): A human promyelocyte mRNA transiently induced by TPA is homologous to the yeast IPP isomerase. Genomics 20:129-131.
47. Xuan JW, Chin JL, Guo Y, Chambers AF, Finkelman MA, Clarke MW (1995a): Alternative splicing of PSP94 (prostate secretory protein of 94 amino acids) mRNA in prostate tissue. Oncogene 11:1041-1047.
48. Xuan JW, Hota C, Shigeyama Y, D'Errico JA, Somerman MJ, Chambers AF (1995b): Site-directed mutagenesis of Arginine-Glycine-Aspartic acid sequence in osteopontin destroys cell adhesion and migration function. J Cell Biochem 57:680-690.
49. Xuan JW, Wlson SM, Chin JL, Chambers AF (1995c): Metastatic NIH 3T3 X LTA cell hybrids express 72 kDa Type IV collagenase. Anticancer Res 15:1227-1234.
50. Xuan JW, Chin JL, Wu M, Guo S, Finkelman M (1996a): The role of prostate secretory protein of 94 amino acids (PSP94) in reproductive biology (Abstract). J Urol 155: 478A.
51. Xuan JW, Wu D, Guo Y, Fraser J, Chin J (1996b): Recombinant PSP94 (prostate secretory protein of 94 amino acids) demonstrates similar linear epitope structure as natural PSP94 protein. J Cell Biochem 63:61-74.